Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Proton therapy Stories

2010-11-16 07:00:00

PALO ALTO, Calif., Nov. 16, 2010 /PRNewswire/ -- Talks on major advances in radiosurgery and radiotherapy for treating cancer of the brain, breast, and spine, captured the attention of more than 800 clinicians at Varian Medical Systems' 2010 Annual Users Meeting, held recently in conjunction with the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Diego. Samuel Ryu, M.D., director of radiosurgery at Henry Ford Hospital in Detroit, Michigan, reported that...

2010-11-08 07:00:00

PARIS, Nov. 8, 2010 /PRNewswire/ -- One of Europe's leading hospitals offering brachytherapy treatments for cancer patients has commenced treatments using three advanced computer-controlled afterloader devices and a full suite of planning software from Varian Medical Systems (NYSE: VAR). French cancer patients will benefit from advanced brachytherapy treatments following the decision by Institute Gustave-Roussy (IGR) in Paris to install Varian's GammaMed(TM) PDR (pulsed dose rate)...

2010-11-05 07:30:00

PALO ALTO, Calif., Nov. 5, 2010 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) is scheduled to present at Lazard Capital Markets Healthcare Conference at 9:30 a.m. ET on Wednesday, November 17th at the St. Regis Hotel in New York City. Participating executives will include Elisha Finney, senior vice president and CFO, and Spencer Sias, vice president of investor relations and corporate communications. The presentation will focus on the company's growth opportunities in radiation...

2010-11-02 17:15:00

JEDDAH, Saudi Arabia, Nov. 2, 2010 /PRNewswire/ -- The Saudi Arabian National Guard Health Affairs ("NGHA") here today announced it has signed an agreement with Varian Medical Systems and IMRIS, Inc., to develop and build a facility for magnetic resonance-guided radiation therapy (MRgRT(TM)). Under the agreement, Varian and IMRIS will supply a cancer treatment solution that combines IMRIS' unique movable magnetic resonance imaging (MRI) technology with Varian's latest linear accelerator...

2010-11-02 07:00:00

HYDERABAD, India, Nov. 2, 2010 /PRNewswire/ -- Advanced cancer treatments across India will become more widely available with the order of four state-of-the-art Varian Medical Systems (NYSE: VAR) medical linear accelerators by Global Hospitals, one of the nation's leading private hospital groups. Three TrueBeam(TM) STx systems and a UNIQUE(TM) accelerator will be installed at Global Hospitals sites in Bangalore, Chennai, Mumbai and Hyderabad in 2011. "This will make some of the world's...

2010-11-01 13:31:39

When treating prostate cancer with radiation therapy, side effects such as urinary problems and rectal pain and bleeding are a concern, as is impact on the patient's overall quality of life. So when new, more efficient treatment methods are developed, one important question is whether better treatment comes at the cost of increased side effects and decreased quality of life. In the case of short-course, high-dose (hypofractionated) radiation therapy, the answer is no, according research at...

2010-11-01 07:15:00

SAN DIEGO, Nov. 1 , 2010 /PRNewswire-FirstCall/ -- ASTRO Booth # 201 -- Varian Medical Systems (NYSE: VAR) has received FDA 510(k) clearance for the Acuros® XB advanced dose calculation algorithm which can complete a RapidArc® treatment plan two to three times faster than conventional planning algorithms. Varian has incorporated the Acuros algorithm for external beam radiotherapy treatment planning into its market-leading Eclipse(TM) treatment...

2010-11-01 07:00:00

SAN DIEGO, Nov. 1, 2010 /PRNewswire/ -- ASTRO Booth # 201 -- The TrueBeam(TM) system for image-guided radiotherapy and radiosurgery, first introduced in the United States in April of this year, is now being used at treatment centers across the United States and Europe to target tumors of the lung, liver, pancreas, head and neck, brain, and spine. The system, which is manufactured by Varian Medical Systems (NYSE: VAR), is currently on display at the annual meeting of the American Society...

2010-10-30 00:00:38

The reality of broadly accessible proton therapy, a minimally invasive treatment for cancer with substantially less treatment related side effects, has come a step closer. P-CURE, a medical device company developing advanced solutions for proton and other radiation therapies, has received Federal Drug Administration (FDA) approval for the P-ART positioning software, which is a critical part of P-CURE's integrated imaging, positioning, and treatment adaptation systems. As a result of...

2010-10-29 07:00:00

PALO ALTO, Calif. and SPRINGFIELD, Va. Oct. 29 /PRNewswire/ -- Varian Medical Systems, Inc. (NYSE: VAR) today announced that CURE Foundation has placed an order for five Varian TrueBeam(TM) systems for stereotactic radiosurgery and radiation therapy. CURE Foundation, which placed the order in September, plans to install the TrueBeam systems in existing and new clinics on the U.S. East Coast during 2011. CURE Foundation was established in Springfield, VA in 2007 as a non-profit...